Improving the health and quality of life of humans and animals is the goal of the research-driven biopharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies. In animal health, Boehringer Ingelheim stands for advanced prevention. Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Around 52,000 employees create value through innovation daily for the three business areas Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.